Drug Type Small molecule drug |
Synonyms multiple oncologic malignancies(CCRP) |
Target |
Action inhibitors |
Mechanism renin receptor inhibitors(ATPase H+ transporting accessory protein 2 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | Germany | 01 May 2026 | |
| Hepatocellular Carcinoma | Preclinical | Germany | 01 May 2026 | |
| Pancreatic Cancer | Preclinical | Germany | 01 May 2026 | |
| Sarcoma | Preclinical | Germany | 01 May 2026 |





